Dr Steven M Guelff

Aspire Health Partners, headquartered in Orlando, Florida, is a comprehensive behavioral healthcare organization dedicated to providing a range of services, including substance abuse treatment, crisis stabilization, and support for co-occurring disorders. Their mission focuses on enhancing community health and well-being through accessible care and educational resources. With multiple facilities across Central Florida, Aspire Health Partners also emphasizes client engagement and satisfaction, inviting feedback from current and former clients. The organization actively supports initiatives such as free Narcan distribution and offers a variety of auxiliary aids for individuals with disabilities. Generated from the website

LifeScan Wellness Center is dedicated to enhancing the lives of individuals with diabetes and related conditions. They offer innovative solutions to support wellness, serving as a global leader in glucose monitoring and diabetes management. With a comprehensive portfolio of products and services, including the widely trusted OneTouch® brand, LifeScan strives to empower millions of consumers worldwide. Committed to improving healthcare, LifeScan fosters partnerships that prioritize patient-centric digital solutions and technologies. Their passionate team of employees is driven by a shared goal of enhancing the quality of life for those living with diabetes. By pioneering advancements in wellness management, LifeScan aims to create a world without limits for individuals facing diabetes and related challenges. Generated from the website content

WellDyne is a full-service pharmacy benefit manager, with 25 years of success keeping clients' pharmacy costs low and quality of care high. Moving beyond the traditional PBM approach, the company leverages technology, data analytics, clinical programs and personalized engagement to manage total cost of care and improve outcomes - particularly in the area of specialty pharmacy. With bold thinking and flawless execution, WellDyne is committed to low-cost, first-line therapies and not just brands with rebates.